Bacteria in the food chain mostly live in communities associated with surfaces known as
biofilms, which confer specific survival and adaptive abilities. In such communities, the …

Bacterial efflux pumps are among the key mechanisms of resistance against antibiotics and
biocides. We investigated whether differential expression levels of the RND-type efflux …

Acinetobacter baumannii is a Gram-negative, opportunistic pathogen that causes infections
in the immunocompromised. With a high incidence of muti-drug resistance, carbapenem …

The spread of microorganisms causing health-care associated infection (HAI) is contributed
to by their intrinsic tolerance to a variety of biocides, used as antiseptics or disinfectants. The …

Antibiotic resistance has become more and more widespread over the recent decades,
becoming a major global health problem and causing colistin to be increasingly used as an …

Acinetobacter baumannii, a pathogenic bacterium acquired in hospitals, causes diverse
infections in humans. Previous studies have reported resistance among A. baumannii …

Hospital-acquired infections are a rising problem with consequences for patients, hospitals,
and health care workers. Biocides can be employed to prevent these infections, contributing …

Over the past few years, l-iminosugars have revealed attractive pharmacological properties
for managing rare diseases including Cystic Fibrosis (CF). The iminosugar N-butyl-l …

The emergence of Acinetobacter baumannii infections as a significant healthcare concern in
hospital settings, coupled with their association with poorer clinical outcomes, has prompted …

Antimicrobial disinfectants have been extensively used to control hospital-acquired
infections worldwide. Prolonged exposure to bacteria could promote resistance to …